• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?

作者信息

Riveiro-Barciela Mar, Muñoz-Couselo Eva, Fernandez-Sojo Jesús, Diaz-Mejia Nely, Parra-López Rafael, Buti María

机构信息

Liver Unit, Internal Medicine Department, Vall d'Hebron Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

Oncology Department, Vall d'Hebron Institut of Oncology (VHIO), Vall d'Hebron Hospital, Barcelona, Spain.

出版信息

J Hepatol. 2019 Mar;70(3):564-566. doi: 10.1016/j.jhep.2018.10.020. Epub 2018 Nov 28.

DOI:10.1016/j.jhep.2018.10.020
PMID:30503040
Abstract
摘要

相似文献

1
Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?血浆置换成功治疗免疫介导性肝炎所致急性肝衰竭：新情况需要新的治疗策略？
J Hepatol. 2019 Mar;70(3):564-566. doi: 10.1016/j.jhep.2018.10.020. Epub 2018 Nov 28.
2
Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?".回复：“血浆置换成功治疗免疫介导性肝炎所致急性肝衰竭：新情况需要新的治疗策略？”
J Hepatol. 2019 Mar;70(3):566-567. doi: 10.1016/j.jhep.2018.11.016. Epub 2018 Dec 5.
3
Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure.急性肝衰竭患者血浆置换去除内毒素和细胞因子。
Crit Care Med. 1998 May;26(5):873-6. doi: 10.1097/00003246-199805000-00021.
4
Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure.血浆置换与持续血液滤过联合应用作为急性肝衰竭患者的临时代谢支持
Artif Organs. 1994 May;18(5):363-6. doi: 10.1111/j.1525-1594.1994.tb02217.x.
5
[Hybrid bioartificial liver for severe hepatitis].[用于重症肝炎的混合生物人工肝]
Zhonghua Gan Zang Bing Za Zhi. 2002 Aug;10(4):305.
6
High-volume plasmaexchange: an effective tool in acute liver failure treatment.大容量血浆置换：急性肝衰竭治疗的有效工具。
Int J Artif Organs. 2002 Aug;25(8):814-5. doi: 10.1177/039139880202500810.
7
High-volume plasma exchange in a patient with acute liver failure due to non-exertional heat stroke in a sauna.一名因在桑拿房非劳力性中暑导致急性肝衰竭患者的大容量血浆置换。
J Clin Apher. 2014 Oct;29(5):281-3. doi: 10.1002/jca.21315. Epub 2014 Feb 4.
8
Prognostic factors and treatment effect of standard-volume plasma exchange for acute and acute-on-chronic liver failure: A single-center retrospective study.标准量血浆置换治疗急性和慢性急性肝衰竭的预后因素及治疗效果：一项单中心回顾性研究。
Transfus Apher Sci. 2018 Aug;57(4):537-543. doi: 10.1016/j.transci.2018.05.030. Epub 2018 Jun 2.
9
Prognostic parameters of pediatric acute liver failure and the role of plasma exchange.儿科急性肝衰竭的预后参数和血浆置换的作用。
Pediatr Neonatol. 2019 Aug;60(4):389-395. doi: 10.1016/j.pedneo.2018.09.006. Epub 2018 Sep 24.
10
Acute liver failure caused by herpes simplex virus in a pregnant patient: is there a potential role for therapeutic plasma exchange?一名孕妇因单纯疱疹病毒引起的急性肝衰竭：治疗性血浆置换有潜在作用吗？
J Clin Apher. 2013 Dec;28(6):426-9. doi: 10.1002/jca.21287. Epub 2013 Jul 16.

引用本文的文献

1
Navigating liver toxicity in the age of novel oncological agents.在新型肿瘤药物时代应对肝毒性问题。
JHEP Rep. 2025 Jun 21;7(9):101473. doi: 10.1016/j.jhepr.2025.101473. eCollection 2025 Sep.
2
Advances in mechanistic investigation and treatment of steroid-refractory ICI-induced liver injury.类固醇难治性免疫检查点抑制剂诱导的肝损伤的机制研究与治疗进展
Clin Exp Med. 2025 Aug 11;25(1):288. doi: 10.1007/s10238-025-01721-z.
3
Immune-Mediated Liver Injury From Checkpoint Inhibitor: An Evolving Frontier With Emerging Challenges.
免疫检查点抑制剂介导的肝损伤：一个充满新挑战的前沿领域。
Liver Int. 2025 Feb;45(2):e16198. doi: 10.1111/liv.16198.
4
Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives.癌症免疫治疗中的肝毒性：诊断、管理及未来展望。
Cancers (Basel). 2024 Dec 29;17(1):76. doi: 10.3390/cancers17010076.
5
Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management.免疫检查点抑制剂所致免疫介导的肝损伤：机制、临床特征与管理
Nat Rev Gastroenterol Hepatol. 2025 Feb;22(2):112-126. doi: 10.1038/s41575-024-01019-7. Epub 2024 Dec 11.
6
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids.英夫利昔单抗治疗类固醇难治性免疫相关性肝炎不会产生肝毒性，并且可能会缩短类固醇治疗时间。
J Immunother Cancer. 2024 Jul 5;12(7):e008074. doi: 10.1136/jitc-2023-008074.
7
The ABC of Immune-Mediated Hepatitis during Immunotherapy in Patients with Cancer: From Pathogenesis to Multidisciplinary Management.癌症患者免疫治疗期间免疫介导性肝炎的基础：从发病机制到多学科管理
Cancers (Basel). 2024 Feb 15;16(4):795. doi: 10.3390/cancers16040795.
8
Effectiveness of tacrolimus in a case of immune checkpoint inhibitor-induced hepatotoxicity that was refractory to steroids and mycophenolate mofetil.他克莫司治疗免疫检查点抑制剂诱导的肝毒性的疗效，该患者对激素和霉酚酸酯耐药。
Clin J Gastroenterol. 2023 Oct;16(5):720-725. doi: 10.1007/s12328-023-01832-8. Epub 2023 Jul 22.
9
Tacrolimus for the Management of Delayed Onset and Treatment-Refractory Immune-Related Hepatitis.他克莫司用于治疗迟发性和治疗难治性免疫相关性肝炎
ACG Case Rep J. 2023 Apr 19;10(4):e01007. doi: 10.14309/crj.0000000000001007. eCollection 2023 Apr.
10
Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives.免疫检查点抑制剂诱导的免疫介导性肝炎：当前进展与未来展望
Front Pharmacol. 2023 Jan 9;13:1077468. doi: 10.3389/fphar.2022.1077468. eCollection 2022.